MCAZ
Menu
Staff Email
FAQs
Whatsapp
Facebook
Twitter
Instagram
Linkedin
Youtube
Menu
Home
About Us
Who We Are
MCAZ Board Members
Careers @ MCAZ
Privacy Policy
Tenders
Corporate Governance
Board Charter
Client Service Charter
Regulatory Functions
Evaluation and Registration
Overview
Find A Registered Medicine
How to Register
Alternative Submission Pathways
Registered & Approved Medicines
Human Medicines Guidelines
Key timelines for the Evaluation and Registration
Important Information
Summary for Product Characteristics
Licensing and Enforcement
Overview
Licensing Process
Inspections
Import & Export
Product Defects & Recalls
Enquiries
Pharmacoviligance and Clinical Trials
Current Projects
Pharmacovigilance Centre
Clinical Trials
WHO Pharmacovigilance Toolkit
Laboratory Services
Medical Devices and Microbiology
Chemistry
Legal and Coperate Affairs
Overview
Legislation
Principal legislation
Procurement Section
Tenders
Request For Quotations
Online Services
Online Registers
Import/Export for Registered Medicines
Section 75 Authorisation
Online Persons and Premises Renewals
ADR E-Reporting
Consumer Reporting
Healthcare Professional Reporting
e-Clinical Trials
Publications
Annual Reports
Press Release
Vaccine Safety
Downloads
RCore Trainings
Contact Us
admin
Comments Off
on Cisatracurium (as besilate) 20mg per vial solution for injection or infusion_4917_SmPC
July 7, 2022
Cisatracurium (as besilate) 20mg per vial solution for injection or infusion_4917_SmPC
Cisatracurium (as besilate) 20mg per vial solution for injection or infusion_4917_SmPC
59
Downloads
Download Now!
Post navigation
Previous Article
Next Article
